TB: Causes, Symptoms, Diagnosis & Treatment

Introduction

Tuberculosis ( TB) is a serious infectious disease that primarily affects the lungs, but can also spread to other parts of the body. It is caused by the bacterium Mycobacterium tuberculosis and is one of the top 10 causes of death worldwide. Despite being a preventable and treatable disease, TB remains a major global health challenge, particularly in developing countries with limited resources.

Causes of TB

TB is caused by the bacterium Mycobacterium tuberculosis, which spreads through the air when an infected person coughs, sneezes, or talks. The TB bacteria are inhaled by others, and if the immune system is unable to stop the bacteria from multiplying, an infection can develop. Several factors increase the risk of developing active TB, including HIV/AIDS, malnutrition, diabetes, smoking, and immunosuppressive medications.

Symptoms of TB

The most common symptoms of active TB disease include:

• Persistent cough lasting three weeks or longer
• Coughing up blood or sputum (mucus from deep inside the lungs)
• Chest pain
• Weakness or fatigue
• Loss of appetite
• Unintentional weight loss
• Fever and chills
• Night sweats

Individuals with latent TB infection do not experience any symptoms, as the bacteria are inactive and not causing illness. However, they may develop active TB disease if their immune system becomes weakened.

Diagnosis of TB

Several tests are used to diagnose TB, including:

• Skin Test (Mantoux or TB Skin Test): This test involves injecting a small amount of purified protein derivative (PPD) under the skin. If a raised, hardened area or swelling develops within 48-72 hours, it may indicate exposure to TB bacteria. Learn more about TB skin testing.
• Blood Test ( Interferon-Gamma Release Assays): This test measures the immune system’s reaction to TB bacteria by detecting the release of a specific protein (interferon-gamma) by white blood cells. Learn more about TB blood tests.
• Chest X-ray: A chest X-ray can detect TB-related changes in the lungs, such as cavities or areas of persistent opacity.
• Sputum Culture and Molecular Tests: If TB is suspected, a sample of sputum (mucus coughed up from the lungs) is collected and tested for the presence of TB bacteria through culture methods or molecular tests like polymerase chain reaction (PCR).

Treatment of TB

TB is treatable with a combination of antibiotics taken for several months. The standard treatment regimen for active TB involves four antibiotics: isoniazid, rifampin, ethambutol, and pyrazinamide. Patients with drug-resistant TB may require additional medications and a longer treatment duration.

Treatment for latent TB infection typically involves taking isoniazid or rifampin alone for several months to prevent the development of active TB disease. Learn more about TB treatment regimens.

Prevention and Control of TB

Preventing the spread of TB involves a combination of strategies, including:

• Vaccination: The Bacillus Calmette-Guérin (BCG) vaccine is widely used in many countries to prevent severe forms of TB in children, but its effectiveness in preventing adult pulmonary TB is limited.
• Infection Control Practices: Measures such as separating infectious patients, proper ventilation, and the use of personal protective equipment (e.g., masks) in healthcare settings can help prevent the spread of TB.
• Early Detection and Treatment: Prompt diagnosis and appropriate treatment of active TB cases help reduce the risk of transmission and prevent the development of drug-resistant strains.
• Public Health Initiatives: Comprehensive programs that address TB at a population level, including screening, treatment support, and addressing social determinants of health, are crucial for controlling the disease.

TB in Special Populations

Certain populations are at higher risk for developing TB or experiencing more severe forms of the disease, including:

• Children: TB in children can be challenging to diagnose and may present with different symptoms, such as failure to thrive or meningitis.
• Elderly: Older adults, particularly those with underlying medical conditions or weakened immune systems, are more susceptible to TB and may experience more severe complications.
• Immunocompromised Individuals: People with HIV/AIDS, those undergoing cancer treatment, or those taking immunosuppressive medications are at higher risk for developing active TB disease.
• Travelers: Individuals traveling to or from areas with high TB rates may be at increased risk of exposure and should consider TB screening and preventive treatment if necessary.

Current Research and Future Directions

Despite significant progress in TB research and control efforts, much work remains to be done. Some areas of active research and future directions include:

• Advances in Diagnostics: Developing more rapid, accurate, and accessible diagnostic tests for TB, particularly for drug-resistant strains, is a priority.
• Innovative Treatments and Drugs: Researchers are exploring new drugs and treatment regimens that are more effective, have fewer side effects, and can address drug-resistant TB.
• Vaccine Research: Efforts are underway to develop more effective TB vaccines that can prevent both latent infection and active disease in all age groups.
• Global TB Control Programs: Strengthening TB control programs, improving access to healthcare, and addressing social determinants of health are crucial for eliminating TB globally.

Through continued research, international collaboration, and a comprehensive public health approach, the goal of eradicating TB as a public health threat can be achieved.